LMO2 and leukemia: Leukemias and clonal dominance in both animal models and human gene therapy clinical trials have been previously linked to insertional activation of LMO2, the MDS1/EVI1 gene complex, HOXB4, and a number of other transcription factor genes, but not previously to activation of an anti-apoptotic gene [30]–[33].